United Therapeutics (UTHR) Tops Q3 EPS by 57c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $498.43 +0.17%
EPS Growth %: -10.1%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -10.1%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $4.16, $0.57 better than the analyst estimate of $3.59. Revenue for the quarter came in at $444.7 million versus the consensus estimate of $421.45 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- General Mills beats estimates as cost savings offset volumes
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
